Key facts
- It has raised $35.6M; the latest was Later Stage VC ($16.0M) in Oct 2024.
- Notable investors include AB Segulah.
- Status: Acquired/Merged (Operating Subsidiary).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Bexa
- ·The full record, as it builds
Funding rounds
No funding rounds for Bexa are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bexa
Developer of a breast tissue analysis tool designed to provide comfortable breast exams to women. The company's tool leverages artificial intelligence to offer a visual mapping system and tactile sensing technology for the detection and assessment of cancer, its population-focused breast cancer early detection examinations using multiple modalities, including a proprietary breast tissue evaluation technology, enabling women who are not protected through traditional breast cancer screening to feel safe.
- Sector
- Healthcare
- HQ
- Rolling Hills Estates, CA, United States
- Founded
- 2001
- Employees
- 80
- Website
- mybexa.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Bexa doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bexa shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bexa in its N-PORT filings yet. We sweep new filings monthly.